REGULATED PRESS RELEASE published on 06/13/2024 at 18:00, 5 months 10 days ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2024 AXA discloses information related to voting rights and shares. Details on share capital, total shares, and voting rights provided according to French Commercial Code and AMF regulations Share Capital Voting Rights French Commercial Code AXA AMF Regulations
BRIEF published on 05/29/2024 at 17:51, 5 months 25 days ago AXA Announces Placement of €750 Million Senior Notes Due 2034 AXA Institutional Investors Debt Refinancing Senior Notes Fixed Annual Coupon
REGULATED PRESS RELEASE published on 05/29/2024 at 17:46, 5 months 25 days ago AXA announces the placement of Euro 750 million senior notes due 2034 AXA announces placement of Euro 750 million senior notes due 2034, with fixed annual coupon of 3.375%. Proceeds to be used for general corporate purposes and debt refinancing AXA Debt Refinancing Senior Notes Euro 750 Million Funding Plan
BRIEF published on 05/16/2024 at 18:05, 6 months 7 days ago AXA Announces Updated Share Capital and Voting Rights Information as of April 30, 2024 Euronext Paris Share Capital Voting Rights AXA Financial Regulation
REGULATED PRESS RELEASE published on 05/16/2024 at 18:00, 6 months 7 days ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2024 AXA discloses information on voting rights and shares in accordance with French Commercial Code and AMF regulations Share Capital Voting Rights French Commercial Code AXA AMF Regulations
BRIEF published on 05/07/2024 at 18:44, 6 months 16 days ago AXA Amends Share Repurchase Agreement to Increase Buy-back Volume Share Repurchase AXA Reinsurance Agreement Anti-dilutive Strategy Stock Price Management
REGULATED PRESS RELEASE published on 05/07/2024 at 18:39, 6 months 16 days ago AXA: Execution of an amendment to the share repurchase agreement dated February 23, 2024, in relation to AXA’s share buy-back program AXA amends share repurchase agreement to increase buy-back amount by Euro 0.2 billion and extend purchase period. Transaction aligned with shareholders' authorization AXA Buy-back Program Share Repurchase Agreement Investment Services Provider Shareholders' Authorization
BRIEF published on 05/02/2024 at 17:52, 6 months 21 days ago AXA Terminates Sale of Life and Pensions Portfolio and Signs Reinsurance Deal Share Buyback AXA Financial Strategy Solvency II Reinsurance Agreement
REGULATED PRESS RELEASE published on 05/02/2024 at 17:47, 6 months 21 days ago AXA announces an agreement to terminate the sale of a closed life and pensions portfolio at AXA Germany, and that AXA Life Europe has entered into a reinsurance agreement for an in-force Savings portfolio AXA terminates sale agreement for closed life and pensions portfolio, enters reinsurance deal for Savings portfolio. Impact on financial targets and Solvency II ratio AXA Financial Targets Sale Agreement Reinsurance Deal Solvency II Ratio
REGULATED PRESS RELEASE published on 05/02/2024 at 17:45, 6 months 21 days ago AXA: 1Q24 Activity Indicators
Published on 11/22/2024 at 23:55, 1 day 1 hour ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 1 hour ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 2 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 2 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 7 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 7 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 8 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 18 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 6 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 7 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 7 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024